Thomas J. Herzfeld Advisors’s Gilead Sciences GILD Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,000	Closed	-$162K	–	321
2017 Q3	$162K	Hold	2,000	–	–	0.07%	115
2017 Q2	$142K	Hold	2,000	–	–	0.06%	119
2017 Q1	$136K	Hold	2,000	–	–	0.06%	137
2016 Q4	$143K	Hold	2,000	–	–	0.07%	124
2016 Q3	$158K	Hold	2,000	–	–	0.08%	108
2016 Q2	$167K	Hold	2,000	–	–	0.09%	115
2016 Q1	$184K	Hold	2,000	–	–	0.1%	119
2015 Q4	$202K	Buy	2,000 +500	+33%	+$52K	0.08%	132
2015 Q3	$147K	Hold	1,500	–	–	0.06%	138
2015 Q2	$176K	Hold	1,500	–	–	0.07%	127
2015 Q1	$147K	Hold	1,500	–	–	0.07%	136
2014 Q4	$141K	Buy	+1,500	New	+$155K	0.07%	143

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thomas J. Herzfeld Advisors's GILD Position: Q4 2017 in Review

Thomas J. Herzfeld Advisors sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 2,000 shares — an estimated $162K sold.

Thomas J. Herzfeld Advisors first reported a position in GILD in Q4 2014 and held it in 12 quarters. The position peaked at $202K in Q4 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Thomas J. Herzfeld Advisors reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 2,000 Gilead Sciences shares in Q4 2017, an estimated $162K.
Thomas J. Herzfeld Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 12 quarters.
Thomas J. Herzfeld Advisors's Gilead Sciences position peaked at $202K in Q4 2015.
1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.